Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19170110

J Surg Oncol 2009 Apr 1 99 5 302-6

Download in:

View as

General Info

PMID
19170110